item1.txt
The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.
The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.
For the three months ended January 31, 2018 and January 31, 2017, the Company recognized approximately $0 and $62,000 of royalty income, respectively, for RadioMobile, which amount has been included within discontinued operations.
During March 2016, the Company announced the shutdown of its Bioconnect division, which comprised the entire operations of the Medical Cabling and Interconnect segment.
The closure is part of the Company’s ongoing plan to close or dispose of underperforming divisions that are not part of the Company’s core operations.
For the three months ended January 31, 2017, the Company recognized approximately $10,000 of income from sale of equipment for the Bioconnect division, which has been included within discontinued operations.
The Company estimates the fair value of the earn-out liability using a probability-weighted scenario of estimated qualifying earn-out gross profit related to Rel-Tech and EBITDA related to Comnet calculated at net present value (level 3 of the fair value hierarchy).
The Company’s current stock incentive plan provides for the granting of qualified and nonqualified options to the Company’s officers, directors and employees.
The Company satisfies the exercise of options by issuing previously unissued common shares.
On December 13, 2017, the Company granted 80,000 incentive stock options to an employee.
No options were granted to Company employees during the three months ended January 31, 2017.
Expected volatilities are based on historical volatility of the Company’s stock price and other factors.


item2.txt
The Company assesses property, plant and equipment and intangible assets, which are considered definite-lived assets, for impairment.
If property and equipment and intangible assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.
The Company amortizes its intangible assets with definite useful lives over their estimated useful lives and reviews these assets for impairment.
These events or circumstances requires significant judgment and could include a significant change in the business climate, legal factors, operating performance indicators, competition and sale or disposition of all or a portion of a division.
This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital.
The earn-out was and will continue to be revalued quarterly using a present value approach and any resulting increase or decrease will be recorded into selling and general expenses.
Accordingly, significant variances between actual and forecasted results or changes in the assumptions can materially impact the amount of contingent consideration expense we record in future periods.
If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital.
Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.


item3.txt



item4.txt
Item 4.
Controls and Procedures 
Nothing to report.


part2.txt
Item 1.
Nothing to report.
Defaults upon Senior Securities 
Nothing to report.
Nothing to report.


